The UK government has said it will end the NHS's controversial contract with US tech firm Palantir, but not until 2029 – two ...
Real-World Evidence for the Impact of Company-Led Medical Education – Medscape Medical Affairs explores the question of ...
Novo has published the results of a clinical trial of its Wegovy injection in children aged six to 12 with obesity, showing ...
Helus Pharma has revealed data from a phase 3 trial of HLP003 that showed evidence of efficacy in major depressive disorder ...
The FDA has said it cannot approve Summit Therapeutics and Akeso's PD-1xVEGF inhibitor ivonescimab, delaying a drug that is ...
Novo Nordisk has said a real-world survey of its weight-loss therapy Wegovy shows it can reduce 'food noise', persistent, intrusive, or repetitive thoughts about eating – even when full – that can be ...
New Orleans hosted this year’s AAPS PharmSci 360 at the Ernest N. Morial Convention Center. For those fortunate enough to ...
AstraZeneca's rare disease unit Alexion has won regulatory approval in the US and EU for Klygefa as a generalised myasthenia ...
Eli Lilly has added yet another name to its list of M&A deals this year after agreeing to buy blood disorder specialist Calytrix Bio for up to $1.5 billion. If it goes through, the deal will give ...
Just a few months after being formed, China's Funnel Biosciences has signed a $2 billion-plus partnership with Third Rock ...
Hims & Hers is also offering compounded formulations of other unapproved peptides, including sermorelin, which some people ...
UK-based startup Oyster Therapeutics has raised $60 million in first-round financing that will be used to advance its tau ...